Biopharma Limited

Biopharma Limited manufactures and markets affordable generic and ethical medicines for healthcare supply channels, with a portfolio of more than 300 pharmaceutical products. Its dosage forms span tablets, capsules, oral liquids and syrups, lotions, gels, creams, ointments, aerosols, medicated soaps and veterinary products. Production is carried out in a GMP-certified plant designed to conform with WHO CGMP norms and stringent international regulatory specifications. The company links research and development, manufacturing, and distribution through quality control measures intended to maintain precision and efficacy across the product lifecycle.

Per-shift manufacturing capacity includes more than 4.2 million tablets, 100,000 capsules, 60,000 oral liquid products, and 30,000 cream and ointment products. Commercial activity encompasses the introduction and marketing of pharmaceutical products for drug wholesalers, pharmaceutical distributors, ministries and health departments, hospitals in public, private, and military settings, clinics, healthcare systems, and affiliated organizations. Through its trade network, the business distributes pharmaceutical products internationally while serving institutional buyers and channel partners across the healthcare sector.